Skip to content
About
Menu Toggle
Team
Board of Directors
Careers
Technology
Menu Toggle
Overview
Antibody Generation
Menu Toggle
Antigen Design
OmniRat
OmniMouse
OmniChicken
Omni
dAb
OmniUltra
OmniTaur
Bispecific Platforms
xPloration Screening
Antibody Optimization
Menu Toggle
Fc-Silencing Technology
Ion Channel and Transporter Technology
In Silico Technologies
Scientific Publications
Partnerships
Menu Toggle
Overview
Why Partner with OmniAb?
Partner Pipeline
Contact Business Development
Investors
Menu Toggle
Overview
News
Events & Presentations
Stock Info
SEC Filings
Financials
Governance
Menu Toggle
Governance Documents
Executive Officers
Board of Directors
Board Committees
Environment
Resources
Menu Toggle
Investor FAQs
Information Request Form
Investor Email Alerts
Investor Contacts
Contact
Main Menu
About
Menu Toggle
Team
Board of Directors
Careers
Technology
Menu Toggle
Overview
Antibody Generation
Menu Toggle
Antigen Design
OmniRat
OmniMouse
OmniChicken
Omni
dAb
OmniUltra
OmniTaur
Bispecific Platforms
xPloration Screening
Antibody Optimization
Menu Toggle
Fc-Silencing Technology
Ion Channel and Transporter Technology
In Silico Technologies
Scientific Publications
Partnerships
Menu Toggle
Overview
Why Partner with OmniAb?
Partner Pipeline
Contact Business Development
Investors
Menu Toggle
Overview
News
Events & Presentations
Stock Info
SEC Filings
Financials
Governance
Menu Toggle
Governance Documents
Executive Officers
Board of Directors
Board Committees
Environment
Resources
Menu Toggle
Investor FAQs
Information Request Form
Investor Email Alerts
Investor Contacts
Contact
OmniUltra™: A New In Vivo Platform for Discovery of Novel Mini-Proteins and Structured Peptides
Post navigation
←
Previous Publication
Next Publication
→
